Development of a Telehealth Obesity Intervention for Patients With MS: Modifying Diet and Exercise in MS — MoDEMS  

Obesity Clinical Trial

Official title: Development of a Telehealth Obesity Intervention for Patients With MS: Modifying Diet and Exercise in MS

Status Completed

Clinical Trial Summary

We will tailor a telehealth obesity intervention for obese patients with MS (figure 2). Half of the patients will be randomly assigned to 24 weekly hour-long group weight loss sessions and 6 monthly individual sessions; half will be assigned to a brief education/Treatment as Usual (TAU) control condition. Participants assigned to the control condition will also receive the active treatment 6 months following their enrollment. As such, we will have feasibility, acceptability, and outcome data for all patients who enroll and complete the intervention. During outpatient recruitment, clinicians will ask obese patients (WHtR >.57, BMI >29) if they would be willing to be contacted about a study investigating a weight loss intervention for patients with MS. Patients who express interest and respond to advertisements will be screened by telephone and via review of medical records. Patients who meet initial eligibility criteria will be invited for a baseline evaluation where they will be formally consented, complete questionnaires and behavioral tasks, and undergo a standardized physical exam. They will be monitored using actigraphy for 10 days. They will then be randomized to the group telehealth obesity intervention or TAU. At 6 months, all participants will undergo a second in-person follow-up assessment and TAU participants will begin the telehealth intervention. At 12 months, participants will undergo a third in-person assessment, providing treatment outcome data for all study participants and long-term weight maintenance data for patients initially assigned to the telehealth obesity intervention. At 18 months, participants initially assigned to the TAU control condition will undergo a 4th assessment, providing weight maintenance data for all enrolled participants.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Multiple Sclerosis
• Obesity

• NCT number: NCT04255953
• Study type: Interventional
• Source: University of Missouri, Kansas City
• Status: Completed
• Phase: N/A
• Start date: August 1, 2020
• Completion date: September 20, 2023